维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="Keefe RS"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis显示文摘	Keefe RS Seidman LJ Christensen BK		0，，02：	1
2	The effects of atypi- cal antipsychotic drugs on neurocognitive impairment in schizo phrenia: a review and meta-analysis 显示文摘	Keefe RS Silva SG Perkins DO	1999	Schlzophr Bull1999，25，2：	1
3	Defining a cognitive function decrement in schizophrenia 显示文摘	Keefe RS Eesley CE Poe MP	2005	Biol Psychiatry2005，57，6：	1
4	The GA single nucleotide polymorphism at -308 position in the tumor necrosis factor-alpha promoter increase the risk for severe sepsis after trauma 显示文摘	O'Keefe GE Hybli DL Munford RS	2002	Trauma2002，52，5：	1
5	Defining a cognitive function decrement in schizophrenia显示文摘	Keefe RS Eesley CE Poe M	2005	Biol Psychiatry2005，57，6：	1
6	Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis:a randomized,double-blind trial of olanzapine versus low doses of haloperidol显示文摘	Keefe RS Seidman LJ Christensen BK		0，，06：	1
7	Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis显示文摘	Keefe RS Seidman LJ Christensen BK	2006	Biol Psychitry2006，59，：	1
8	The effects of atypical antipsyehotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis 显示文摘	Keefe RS Silva SG Perkins DO	1999	Schizophr Bull1999，25，2：	1
9	The FDA- NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? 显示文摘	Buchanan RW Keefe RS Umbricht D	2011	Schizophr Bull2011，37，6：	1
10	A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia 显示文摘	Buchanan RW Keefe RS Lieberman JA	2011	Biol Psychiatry2011，69，5：	1
11	Schizophrenia is a cognitive illness: time for a change in focus 显示文摘	Kahn RS Keefe RS	2013	JAMA Psychiatry2013，70，10：	1
12	Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment显示文摘	Harvey PD Keefe RS	2001	Am J Psychiatry2001，158，2：	1
13	Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and nega- tive symptoms in schizophrenia显示文摘	Marx CE Keefe RS Buchanan RW	2009	Neuropsychopharmaeology2009，34，8：	1
14	Report of an international workshop:Roadmap for management of patients receiving oral therapy for chronic hepatitis B显示文摘	Keefe EB Zeuzem S Koff RS	2007	Clin Gastroenterol Hepatol2007，5，8：	1
15	Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12 week, randomized, double blind, placebo-controlled trial 显示文摘	Keefe RS Malhotra AK Meltzer HY	2008	Neuropsyehopharmacology2008，33，6：	1
16	The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia:a review and meta-analysis显示文摘	Keefe RS Silva SG Perkins DO	1999	Schizophr Bull1999，25，2：	1
17	One - year double - blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia 显示文摘	Keefe RS Young CA Rock SL	2006	Schizophr Res2006，81，1：	1
18	A randomized clinical trial of MK-0777 for the treatment of eosnltlve impairments in people with schizophrenia显示文摘	Buchanan RW Keefe RS Lieberman JA	2011	Biol Psychiatry2011，69，5：	1
19	Studies of cognitive change in patients with schizophrenia following novel antipsycbotic treatment 显示文摘	Harvey PD Keefe RS	2001	Am J Psychiatry2001，158，2：	1
20	The G-A single nueleo- tide polymorphism the-308 position in the tumor necrosis fae- tor-alpha promoter increases the risk for severe sepsis after tra 显示文摘	O'Keefe GE Hybki DL Manford RS	2002	J Traanm2002，52，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示